OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NEXAM59

Nexam Chemical Holding AB

Specialty ChemicalsVerified

Nexam Chemical Holding AB operates with a relatively low debt-to-equity ratio of 0.12, indicating a conservative capital structure. The company's liquidity position is characterized as medium, with a current ratio of 2.17, suggesting it can cover its short-term obligations but with limited excess capacity. Despite this, the company reported negative net income of -1.35 million SEK and an operating loss of -0.95 million SEK, which is a concern for profitability. The company's return on equity (ROE) is -0.71%, and its return on assets (ROA) is -0.53%, both of which are negative and indicate poor performance relative to its equity and asset base. These metrics are below the typical expectations for a specialty chemicals firm, suggesting that the company is not generating sufficient returns to justify its capital investments. Nexam's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. The company's geographic exposure is not explicitly detailed, but given its listing on the Stockholm Exchange, it is likely to have a significant presence in the Nordic region. The lack of segmental and geographic diversification increases the company's vulnerability to regional economic downturns or sector-specific disruptions. The company's growth trajectory appears to be under pressure, with a reported revenue of 53.93 million SEK and a negative operating income. Analysts have estimated a mean revenue of 207 million SEK for the next period, which is significantly higher than the last actual revenue of 192.25 million SEK. However, the mean EBIT estimate is -7 million SEK, indicating continued operational challenges. The discrepancy between the revenue and EBIT estimates suggests that while the company may see some top-line growth, it is unlikely to translate into improved profitability. The risk assessment for Nexam highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could constrain its ability to fund operations or invest in growth opportunities. The low dilution risk is attributed to the absence of significant dilution sources in the available data, although the company's negative earnings and cash flow could necessitate future equity raises. Recent events and filings indicate that Nexam is facing operational and financial challenges. The company's negative earnings and cash flow, combined with a negative ROE and ROA, suggest that it is struggling to generate value for shareholders. The company's management will need to address these issues to restore investor confidence and improve its financial performance.

30-day price · NEXAM(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyNexam Chemical Holding AB
TickerNEXAM.ST
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Nexam Chemical Holding AB is a specialty chemicals company that produces and distributes chemical products for industrial and consumer applications.

Classification. Nexam is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Nexam Chemical Holding AB operates with a relatively low debt-to-equity ratio of 0.12, indicating a conservative capital structure. The company's liquidity position is characterized as medium, with a current ratio of 2.17, suggesting it can cover its short-term obligations but with limited excess capacity. Despite this, the company reported negative net income of -1.35 million SEK and an operating loss of -0.95 million SEK, which is a concern for profitability. The company's return on equity (ROE) is -0.71%, and its return on assets (ROA) is -0.53%, both of which are negative and indicate poor performance relative to its equity and asset base. These metrics are below the typical expectations for a specialty chemicals firm, suggesting that the company is not generating sufficient returns to justify its capital investments. Nexam's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. The company's geographic exposure is not explicitly detailed, but given its listing on the Stockholm Exchange, it is likely to have a significant presence in the Nordic region. The lack of segmental and geographic diversification increases the company's vulnerability to regional economic downturns or sector-specific disruptions. The company's growth trajectory appears to be under pressure, with a reported revenue of 53.93 million SEK and a negative operating income. Analysts have estimated a mean revenue of 207 million SEK for the next period, which is significantly higher than the last actual revenue of 192.25 million SEK. However, the mean EBIT estimate is -7 million SEK, indicating continued operational challenges. The discrepancy between the revenue and EBIT estimates suggests that while the company may see some top-line growth, it is unlikely to translate into improved profitability. The risk assessment for Nexam highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could constrain its ability to fund operations or invest in growth opportunities. The low dilution risk is attributed to the absence of significant dilution sources in the available data, although the company's negative earnings and cash flow could necessitate future equity raises. Recent events and filings indicate that Nexam is facing operational and financial challenges. The company's negative earnings and cash flow, combined with a negative ROE and ROA, suggest that it is struggling to generate value for shareholders. The company's management will need to address these issues to restore investor confidence and improve its financial performance.
Key takeaways
  • Nexam Chemical Holding AB has a conservative capital structure with a low debt-to-equity ratio of 0.12.
  • The company's profitability is weak, with a negative ROE of -0.71% and a negative ROA of -0.53%.
  • Nexam's revenue is concentrated in a single business segment, increasing its vulnerability to sector-specific risks.
  • Analysts expect continued operational challenges, with a mean EBIT estimate of -7 million SEK for the next period.
  • The company's liquidity position is medium, and its net cash position is negative after subtracting total debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySEK
Revenue$53.9M
Gross profit$25.2M
Operating income-$954.0k
Net income-$1.4M
R&D
SG&A
D&A
SBC
Operating cash flow$8.1M
CapEx
Free cash flow$2.2M
Total assets$253.6M
Total liabilities$64.1M
Total equity$189.5M
Cash & equivalents
Long-term debt$22.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$219.9M-$4.3M-$5.5M-$2.1M
FY-3$223.0M-$11.9M-$12.7M-$34.3M
FY-2$191.3M-$20.5M-$22.8M-$18.3M
FY-1$200.4M-$7.3M-$9.0M-$3.8M
FY0$193.3M-$13.0M-$16.5M-$7.8M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$284.3M$228.1M
FY-3$278.1M$215.6M
FY-2$245.8M$193.1M
FY-1$237.3M$183.3M
FY0$226.0M$168.2M
PeriodOCFCapExFCFSBC
FY-4$7.2M-$6.7M-$2.1M
FY-3-$11.1M-$33.1M-$34.3M
FY-2-$352.0k-$9.2M-$18.3M
FY-1$7.4M-$9.9M-$3.8M
FY0$11.3M-$9.6M-$7.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$53.9M-$954.0k-$1.4M$2.2M
FQ-6$44.1M-$2.5M-$2.7M$950.0k
FQ-5$48.8M-$2.5M-$3.0M$1.5M
FQ-4$49.4M-$2.8M-$4.1M$12.0k
FQ-3$54.3M-$2.8M-$3.3M$751.0k
FQ-2$46.5M-$3.3M-$3.9M$161.0k
FQ-1$43.1M-$4.1M-$5.2M$831.0k
FQ0$43.9M-$5.5M-$6.2M-$2.1M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$253.6M$189.5M
FQ-6$240.8M$186.6M
FQ-5$237.3M$183.3M
FQ-4$231.2M$179.3M
FQ-3$240.5M$177.0M
FQ-2$233.7M$173.2M
FQ-1$226.0M$168.2M
FQ0$264.0M$206.8M
PeriodOCFCapExFCFSBC
FQ-7$8.1M$2.2M
FQ-6$9.0M$950.0k
FQ-5$7.4M$1.5M
FQ-4$1.9M$12.0k
FQ-3$652.0k$751.0k
FQ-2$8.8M$161.0k
FQ-1$11.3M$831.0k
FQ0-$4.9M-$2.1M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$189.5M
Net cash-$22.2M
Current ratio2.2
Debt/Equity0.1
ROA-0.5%
ROE-0.7%
Cash conversion-6.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricNEXAMActivity
Op margin-1.8%5.5% medp25 -0.0% · p75 10.8%bottom quartile
Net margin-2.5%4.1% medp25 0.1% · p75 8.8%bottom quartile
Gross margin46.7%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity12.0%37.1% medp25 10.3% · p75 82.0%below median
Observations
IR observations
Mean EPS estimate-0.07 SEK
Last actual EPS-0.19 SEK
Mean revenue estimate207,000,000 SEK
Last actual revenue192,245,000 SEK
Mean EBIT estimate-7,000,000 SEK
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 20:56 UTC#72a74360
Market quoteclose SEK 2.51 · shares 0.10B diluted
no public URL
2026-05-08 02:02 UTC#dd94c37d
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 17:48 UTCJob: 951a33a8